A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus
Clinical trial NCT04700267 · TERMINATED
Trial details
- NCT number
- NCT04700267
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-28
- Primary completion
- 2021-10-06
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.